Hemoglobin A1c test is a blood test which analyzes the amount of the red blood cells (RBC) in your blood. It helps to determine whether a patient have type A or B blood, and also assess the extent of liver disease. Hemoglobin is an A-shaped molecule which consists of three carbon atoms and one oxygen atom. The molecule may either be dimerized (two carbon atoms with one oxygen atom) or non-dimerized (no carbon atoms with one oxygen atom). The molecule’s shape, size and function are important factors in determining whether it is A1c compatible or not.
The hemoglobin a1c test measures the amount of hemoglobin which is absorbed by the red blood cells. When present in the blood, hemoglobin discharges waste products and combines with the nutrients which are transported to the red blood cells.
Statistics:
The global hemoglobin A1c testing devices market is estimated to account for US$ 4,129.4 Mn in terms of value by the end of 2027.
Market Drivers
Growing prevalence of diabetes is driving growth of the global hemoglobin A1c testing devices market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/945
Additionally, growing geriatric population is also increasing prevalence of diabetes which is again expected to aid in growth of the market. For according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Statistics:
North America held leading position in the global hemoglobin A1c testing devices market in 2019, accounting for 36.8% share in terms of value, followed by Europe and Asia Pacific, respectively
Global Hemoglobin A1c Testing Devices Market: Restraints
Factor such as high test cost is expected to hinder growth of the global hemoglobin A1c testing devices market. Laboratory testing of hemoglobin A1c is a costly and time consuming process, which restricts patients from seeking A1C testing. Moreover, healthcare practitioners prefer blood glucose testing in case of emergencies.
Also, low adoption rate of hemoglobin A1c testing in emerging economies due to the lack of awareness and acceptance of hemoglobin A1c testing method is again expected to support growth of the market.
Global Hemoglobin A1c Testing Devices Market: Opportunities
High cases of undiagnosed diabetes in emerging countries is expected to offer bright growth opportunities for players in the market. For instance, according to the study, ‘The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes, and Prediabetes’, published in the journal Diabetes Care, in April 2019, the economic burden associated with diagnosed diabetes, undiagnosed diabetes, prediabetes (adults), and gestational diabetes (mothers and newborns) reached US$ 327.2 billion, US$ 31.7 billion, US$ 43.4 billion for prediabetes, and US$ 1.6 billion for gestational diabetes, respectively, in 2017, in the U.S.
Moreover, advent of cost-effective HbA1c tests and devices is again expected to aid in growth of the market.
Statistics:
The global hemoglobin A1c testing devices market was valued at US$ 1,863.7 Mn in 2019 and is forecast to reach a value of US$ 4,129.4 Mn by 2027 at a CAGR of 10.5% between 2020 and 2027.
Market Trends/Key Takeaways
The current trend is shifting towards the Clinical Laboratory Improvement Amendments (CLIA) waived tests and hence producing CLIA waived tests will bolster the demand for CLIA waived HbA1c testing devices. Additionally, advent of CLIA waived POC HbA1c testing devices will favor the market growth for POC devices and thus in turn will be beneficial for both manufacturers as well as customers.
Several research studies have revealed higher efficacy of glucose tolerance test over hemoglobin A1c blood test. For instance, in March 2019, a study by City of Hope Diabetes and Metabolism Research Institute, published at the Endocrine Society’s ENDO 2019, reported that hemoglobin A1c blood test missed almost 73% of the people with diabetes in comparison to the oral glucose tolerance test.
Christmas Sale is Live!!!!!
Buy Now and Get 25-30% of Discount on this report
Buy-Now this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/945
Global Hemoglobin A1c Testing Devices Market: Competitive Landscape
Key players engaged in the global hemoglobin A1c testing devices market include, Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Chek Diagnostics (Polymer Technology Systems, Inc.), Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation, and Trinity Biotech plc.
Global Hemoglobin A1c Testing Devices Market: Key Developments
Key players are focused on introducing new products to expand their product portfolio. For instance, in June 2019, Abbott Laboratories launched Afinion HbA1c Dx test, a 3-minute, in-office A1c blood test for diagnosing diabetes.
Similarly, in May 2019, Siemens Healthineers launched its new Atellica CH Enzymatic Hemoglobin A1c Assay to for diagnosing and monitoring diabetes.
To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/945
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Technology
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Technological Advancements
- Regulatory Scenario
- Mergers and Acquisitions
- Market Dynamics
- Hemoglobin A1c Testing Devices Market, By Test Type, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Laboratory Testing Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Point-of-care Testing Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Hemoglobin A1c Testing Devices Market, By Technology, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Ion-Exchange HPLC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Immunoassay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Boronate Affinity Chromatography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Direct Enzymatic Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837